Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79.

Davis TM, Coleman RL, Holman RR; UKPDS Group.

Circulation. 2013 Mar 5;127(9):980-7. doi: 10.1161/CIRCULATIONAHA.112.000908. Epub 2013 Jan 29.

2.

Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort.

Tao L, Wilson EC, Griffin SJ, Simmons RK; ADDITION-Europe study team.

Value Health. 2013 Sep-Oct;16(6):1074-80. doi: 10.1016/j.jval.2013.06.001. Epub 2013 Aug 7.

3.

Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66.

Stevens RJ, Coleman RL, Adler AI, Stratton IM, Matthews DR, Holman RR.

Diabetes Care. 2004 Jan;27(1):201-7.

PMID:
14693990
4.

Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.

Nilsson PM, Cederholm J, Eeg-Olofsson K, Eliasson B, Zethelius B, Fagard R, Gudbjörnsdóttir S; Swedish National Diabetes Register.

Eur J Cardiovasc Prev Rehabil. 2009 Aug;16(4):506-12. doi: 10.1097/HJR.0b013e32832ccc50.

PMID:
19561510
6.

[Factors influencing cardiac complications in patients with type-2 diabetes mellitus and silent myocardial ischaemia: five-year follow-up].

Mamcarz A, Chmielewski M, Braksator W, Syska-Sumńska J, Janiszewski M, Król J, Kuch M, Kuch J, Dłuiniewski M.

Pol Arch Med Wewn. 2004 Dec;112(6):1433-43. Polish.

PMID:
15962608
8.

Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.

Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA.

Circulation. 2004 Sep 21;110(12):1572-8. Epub 2004 Sep 13.

9.

The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study.

Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM; PROactive Investigators.

J Am Coll Cardiol. 2007 May 1;49(17):1772-80. Epub 2007 Apr 16.

10.

Is silent myocardial infarction more common in women with type 2 diabetes than in men?

Stiles MC, Seaquist ER, Yale JF, Green JB, Katz LA, Kempainen S, Light LS, Pepper PV, Zhang ZM, Soliman EZ.

J Diabetes Complications. 2012 Mar-Apr;26(2):118-22. doi: 10.1016/j.jdiacomp.2012.02.002. Epub 2012 Mar 24.

11.

Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus.

Lutgers HL, Gerrits EG, Graaff R, Links TP, Sluiter WJ, Gans RO, Bilo HJ, Smit AJ.

Diabetologia. 2009 May;52(5):789-97. doi: 10.1007/s00125-009-1308-9. Epub 2009 Mar 10.

PMID:
19274450
12.
13.

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR, Holman RR.

BMJ. 1998 Mar 14;316(7134):823-8.

14.

Race and Sex Differences in the Incidence and Prognostic Significance of Silent Myocardial Infarction in the Atherosclerosis Risk in Communities (ARIC) Study.

Zhang ZM, Rautaharju PM, Prineas RJ, Rodriguez CJ, Loehr L, Rosamond WD, Kitzman D, Couper D, Soliman EZ.

Circulation. 2016 May 31;133(22):2141-8. doi: 10.1161/CIRCULATIONAHA.115.021177. Epub 2016 May 16.

15.

Insulin sensitivity at diagnosis of Type 2 diabetes is not associated with subsequent cardiovascular disease (UKPDS 67).

Adler AI, Levy JC, Matthews DR, Stratton IM, Hines G, Holman RR.

Diabet Med. 2005 Mar;22(3):306-11.

PMID:
15717879
16.

Proenkephalin and prognosis after acute myocardial infarction.

Ng LL, Sandhu JK, Narayan H, Quinn PA, Squire IB, Davies JE, Bergmann A, Maisel A, Jones DJ.

J Am Coll Cardiol. 2014 Jan 28;63(3):280-9. doi: 10.1016/j.jacc.2013.09.037. Epub 2013 Oct 16.

17.

10-year follow-up of intensive glucose control in type 2 diabetes.

Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA.

N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.

18.

Increased risk of subsequent myocardial infarction in patients with type 2 diabetes: a retrospective cohort study using the U.K. General Practice Research Database.

Liang H, Vallarino C, Joseph G, Manne S, Perez A, Zhang S.

Diabetes Care. 2014;37(5):1329-37. doi: 10.2337/dc13-1953. Epub 2014 Mar 4.

PMID:
24595635
19.

The prevalence and prognosis of unrecognized myocardial infarction and silent myocardial ischemia in patients undergoing major vascular surgery.

Feringa HH, Karagiannis SE, Vidakovic R, Elhendy A, ten Cate FJ, Noordzij PG, van Domburg RT, Bax JJ, Poldermans D.

Coron Artery Dis. 2007 Nov;18(7):571-6.

PMID:
17925612
20.

UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82.

Hayes AJ, Leal J, Gray AM, Holman RR, Clarke PM.

Diabetologia. 2013 Sep;56(9):1925-33. doi: 10.1007/s00125-013-2940-y. Epub 2013 Jun 22.

PMID:
23793713

Supplemental Content

Support Center